No Data
No Data
Polaris Renewable Energy Announces Q2 2024 Investor Call Details
TORONTO, ON / ACCESSWIRE / July 22, 2024 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris" or the "Company") is pleased to announce it will be holding its Earnings Conference Call and Webcast to
Centamin PLC Announces Early Completion of Waste Stripping Programme
PERTH, AUSTRALIA / ACCESSWIRE / July 18, 2024 / Centamin plc ("Centamin", "Group" or "the Company") (LSE:CEY)(TSX:CEE)EARLY COMPLETION OF 120MT CONTRACT WASTE STRIPPING PROGRAMMEMARTIN HORGAN, CEO,
Nexera Announces Delayed Filing of Annual Financial Statements and MD&A and Application for Management Cease Trade Order
CALGARY, AB and SAN ANTONIO, TX / ACCESSWIRE / July 16, 2024 / Nexera Energy Inc. (TSX Venture:NGY)(OTC PINK:EMBYF) (the "Corporation", the "Company" or "Nexera") would like to provide an update on
Hemogenyx Pharmaceuticals PLC Announces Result of Annual General Meeting
LONDON, UNITED KINGDOM / ACCESSWIRE / June 27, 2024 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that, at the Annual General Meeting ("AGM") held earlier today, all resolutions we
Simplify Health Care ETF Declares Quarterly Distribution of $0.0300
Kuros Biosciences Announces Peer-Reviewed Publication Of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft
ZURICH, SWITZERLAND / ACCESSWIRE / June 25, 2024 / Kuros Biosciences, a leader in next generation bone healing technologies, today announced the publication of a peer-reviewed manuscript that details